October
27
  7:03:41 PM

Surrogacy thrives in China, despite illegality

While surrogacy is illegal in China, it is booming under lax oversight. The Shanghai Daily reports that shady surrogacy companies which only reveal their location after a down-payment, have developed “baby-selling packages”. Surrogacy agency daiyunzj.com promised an undercover reporter posing as a customer that for 1 million yuan (US$150,000), the company would enlist 5-7 surrogate mothers and impregnate them with the customer’s sperm all at once, solely to ensure that at least one baby is a boy.

Daiyunzj.com said that for a baby of random gender would cost only about 150,000 yuan. A company official surnamed Wang said that female foetuses who are not wanted are aborted. If all babies are girls, the mothers have to keep getting pregnant after abortions, Wang says. In the more likely situation that two or more babies are male, the customer chooses a mother to carry the foetus to term, and the other babies are aborted. The customer might choose to “purchase extra babies, boys or girls”, Wang says, for 15,000 to 30,000 yuan each.

“What you have to do is to make sure that your sperms are active and pay the fees, then we supply the eggs and mothers to ensure that you have your son in two years,” said Wang. ~ Shanghai Daily, Oct 22




 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Indian surrogate for US woman dies in Gurjarat
18 May 2012
Do reproductive rights survive gender reassignment?
19 May 2012
South African activists begin euthanasia campaign
19 May 2012
70 assisted suicides in Washington state in 2011
19 May 2012
Would-be grandparents pay for their daughters’ egg freezing
19 May 2012

 Tags
organ donation, organ trafficking, Canada, India, informed consent, China, neuroscience, euthanasia, UK, Down syndrome, research, law, suicide, embryonic stem cells, sex selection, Australia, bioethics, commercialization, organ transplants, abortion, human drama, US, IVF, stem cells, assisted suicide, sperm donation, surrogacy, clinical trials, Netherlands, genetic testing,